Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.

Duolin Respules

Generic: Levosalbutamol/Ipratropiumby Cipla Limited

Buy Duolin Respules (Levosalbutamol/Ipratropium) online | SafeRxPills

Select pack size

1
Free shipping over $149
Free reshipment if lost
Discreet packaging
WHO-GMP certified
Secure checkout

Similar medicines

View all
Buy Duolin Rotacaps (Levosalbutamol/Ipratropium) online | SafeRxPills

Duolin Rotacaps

$11.13View
Buy Levolin 0.63mg Respules (Levosalbutamol) online | SafeRxPills

Levolin 0.63mg Respules

$13.00View
Buy Aerocort Forte Rotacaps (Beclometasone/Levosalbutamol) online | SafeRxPills

Aerocort Forte Rotacaps

$11.00View
Buy Aerocort Inhaler (Beclometasone/Levosalbutamol) online | SafeRxPills

Aerocort Inhaler

$11.00View

About Duolin Respules

Duolin Respules are single-dose plastic ampoules (respules) of nebuliser solution made in India by Cipla. Cipla's prescribing information gives each 2.5 mL respule as levosalbutamol sulphate 1.25 mg with ipratropium bromide 500 mcg, and the PharmEasy and Apollo listings give the same. Levosalbutamol (called levalbuterol in the US) is a short-acting beta2 agonist bronchodilator; ipratropium is a short-acting antimuscarinic (anticholinergic) bronchodilator. The solution is breathed in as a mist through a nebuliser. Cipla's label is for chronic obstructive pulmonary disease (COPD) only. We sell packs of 30, 60 and 90 respules, from $0.82 a respule in the 90 pack.

Four points first. No nebuliser solution that combines levosalbutamol with ipratropium is approved by the FDA or Health Canada, and we found none licensed by the MHRA or registered with the TGA. The closest licensed product, ipratropium with salbutamol (sold in the US as generic ipratropium and albuterol solution, formerly the brand DuoNeb), uses racemic salbutamol (albuterol), not levosalbutamol, so Duolin is not a generic of it. Cipla's label makes one respule three times a day the maximum recommended daily dose, and says that, in general, people aged 65 and over should be started on 0.63 mg of levosalbutamol, half the amount in a Duolin respule. And in the US, the licensed salbutamol version costs pharmacies about $0.23 to $0.24 a vial, far less than ours.

Duolin Respules at a glance

Active ingredientsLevosalbutamol sulphate 1.25 mg and ipratropium bromide 500 mcg per 2.5 mL respule (Cipla prescribing information; PharmEasy and Apollo listings)
Brand and makerDuolin, by Cipla Limited, India. Cipla's prescribing information names its Verna, Goa site; PharmEasy names a Cipla site in Rorathang, Sikkim
FormNebuliser solution in single-dose respules; needs a jet nebuliser and an air compressor
Used forCOPD in people already on a regular bronchodilator who still have bronchospasm and need a second bronchodilator (Cipla label). Not a children's medicine
Regulatory statusLevosalbutamol with ipratropium: not approved by the FDA or Health Canada; we found no MHRA licence or TGA registration. Ipratropium with racemic salbutamol is licensed in the US, UK and Canada
Usual dose from the labelAdults and children over 12: one respule three times a day, every 6 to 8 hours; this is the maximum recommended daily dose (Cipla)
TimingCipla's patient information says it may help open your airways for up to 5 hours. In the US trial of the racemic salbutamol version, peak effect came at a mean of 1.5 hours
Packs30, 60 and 90 respules. The carton in our product photo reads 4 x 5 x 2.5 ml (four foil pouches of five)
Price per respule$1.10 (30 pack) down to $0.82 (90 pack), before shipping
Delivery7 to 14 business days to the US, UK, Australia and Canada; $25 shipping under $149, free from $149

Price per respule

Prices below are as of October 2026; the pack selector shows the current price.

PackPricePer respuleShippingPer respule with shippingLasts at 3 a day (our arithmetic)
30 respules$33.00$1.10$25$1.9310 days
60 respules$52.50$0.88$25$1.2920 days
90 respules$73.75$0.82$25$1.1030 days

All three packs are under the $149 free shipping line, so each order carries $25 shipping. The larger packs are cheaper per respule before shipping too. The last column uses Cipla's labelled maximum of three respules a day; it is our arithmetic, not a label figure. If your doctor has you on fewer doses, a pack lasts longer. Check that the expiry date on the pouches covers the weeks you need before you buy the 90 pack.

Compared with the licensed salbutamol version and US generics

Product (not the same as Duolin)Contents per doseFDA approvedCost per dose
Duolin Respules (ours)Levosalbutamol 1.25 mg with ipratropium 0.5 mg in 2.5 mLNo$0.82 to $1.10, our price before shipping
Generic ipratropium and albuterol inhalation solution (formerly DuoNeb)Racemic albuterol 2.5 mg with ipratropium 0.5 mg in 3 mLYesAbout $0.23 to $0.24 a vial (NADAC $0.07646 to $0.08078 per mL)
Generic levalbuterol 1.25 mg/3 mL vial plus generic ipratropium 0.5 mg/2.5 mL vialThe same two medicines as Duolin, as two separate vialsYes, each on its ownAbout $1.08 to $1.42 for the pair (NADAC $0.27361 to $0.37720 per mL and $0.10348 to $0.11350 per mL)
Generic ipratropium 0.02% vial aloneIpratropium 0.5 mg in 2.5 mLYesAbout $0.26 to $0.28 a vial

NADAC (National Average Drug Acquisition Cost) is what US pharmacies pay to buy a medicine, published by the US Medicaid programme; it is not the price a patient pays at the counter. All rows are from the NADAC file dated 21 October 2026, with an effective date of 21 October 2026. Per vial figures are our arithmetic from the per mL rates and the vial volume. There is no NADAC row for the DuoNeb brand, which the FDA lists as discontinued, with a Federal Register determination that it was not withdrawn for safety or effectiveness reasons. Cipla itself makes one of the US generic ipratropium and albuterol solutions, for Cipla USA; it contains racemic albuterol and is a different product from Duolin.

Said plainly: if you are in the US and have a prescription, the licensed ipratropium and albuterol solution costs pharmacies about $0.23 to $0.24 a dose, against our $0.82 to $1.10 before shipping, and your insurance or a local cash price may beat ours too. Ask your doctor or pharmacist about it first. Separate US levalbuterol and ipratropium vials cost pharmacies $1.08 to $1.42 a dose, in the same range as ours once shipping is included.

Levosalbutamol compared with racemic salbutamol

Salbutamol (albuterol) is a 50:50 mix of two mirror-image forms; levosalbutamol is the active (R) form on its own. So the 1.25 mg of levosalbutamol in one Duolin respule is the same amount of the R form as in a 2.5 mg salbutamol dose (our arithmetic). It is not a lower beta agonist dose. The US levalbuterol label (12.2, 12.3) reports that a single 1.25 mg levalbuterol dose gave about twice the R-albuterol exposure of 2.5 mg racemic albuterol (AUC 3.3 against 1.7 ng.h/mL), that bronchodilation was clinically comparable over 6 hours apart from a slightly longer effect with 1.25 mg, and that 1.25 mg "produced a slightly higher rate of systemic beta-adrenergic adverse effects than the 2.5 mg dose of racemic albuterol". Cipla's Duolin prescribing information repeats these findings. Our salbutamol vs levosalbutamol guide covers the wider evidence.

What the evidence covers

The trial evidence for this kind of combination comes from the racemic version. In the US label's 12 week study of 863 people with COPD, ipratropium with albuterol gave a significantly better peak rise in lung function (FEV1) than either medicine alone, with a mean time to peak of 1.5 hours and a 15% response lasting 4.3 hours. We found no published clinical trial of a fixed levosalbutamol with ipratropium nebuliser solution such as Duolin (PubMed searches, 22 October 2026). The two medicines have been given together in a few studies: in a 6 week US trial of levalbuterol in 209 people with COPD, ipratropium 0.5 mg was added at one clinic visit (Donohue 2006), and in an emergency department trial in 141 adults with severe acute asthma, adding ipratropium to levalbuterol did not improve FEV1 or hospital admission rates, and a post hoc analysis found more side effects such as palpitations (Cydulka 2010). A laboratory study found that levalbuterol 1.25 mg mixed with ipratropium 0.5 mg stayed physically and chemically compatible for at least 30 minutes (Bonasia 2008); it measured stability in the cup, not effects in patients.

Regulatory status outside India

Each medicine in Duolin is licensed somewhere on its own, but we found the pair licensed in none of the four countries we ship to. We checked the FDA's approvals database (openFDA), Health Canada's Drug Product Database and the UK medicines compendium (emc) on 22 October 2026; an earlier search of the MHRA products database (16 October 2026) found no levosalbutamol licence of any kind in the UK.

  • US: no product with levalbuterol and ipratropium. Ipratropium with albuterol nebuliser solution is sold as generics (the DuoNeb brand is discontinued); levalbuterol solution and ipratropium solution are each sold as generics.
  • UK: Combivent UDVs (ipratropium 500 mcg with salbutamol 2.5 mg in 2.5 mL) and Atrovent UDVs (ipratropium alone) are prescription only medicines on the emc. No levosalbutamol product found.
  • Canada: Teva-Combo Sterinebs and a Juno ipratropium with salbutamol inhalation solution are marketed as prescription products; the Combivent UDV is cancelled. No levalbuterol or levosalbutamol product in the database.
  • Australia: ipratropium nebuliser solutions are Schedule 4 (prescription only). healthdirect lists no current ipratropium with salbutamol product, and we could not confirm an Australian registration for levosalbutamol.
  • India: Cipla's prescribing information cites a manufacturing licence (No. 536, 7 March 2011) for the 2.5 mL respule. We did not find levosalbutamol with ipratropium in the Central Drugs Standard Control Organisation's published lists of approved fixed dose combinations; we checked the list to December 2019 and the later lists we could download, which cover most of the period from 2020 to March 2025. The lists do include ipratropium 500 mcg with salbutamol 2.5 mg per 2.5 mL respiratory solution (3 April 2001).

Which strength to choose

Indian pharmacies list three Duolin respules. We sell only the 2.5 mL version on this page.

ProductContents per respuleWhere it sits against the labels
Duolin LD (we do not sell it)Levosalbutamol 0.63 mg with ipratropium 500 mcg in 2.5 mL (PharmEasy)0.63 mg is the US levalbuterol starting dose for age 12 and over, and the starting dose both Cipla and the US label give for people aged 65 and over
Duolin Respules (this page)Levosalbutamol 1.25 mg with ipratropium 500 mcg in 2.5 mLCipla: one respule three times a day is the maximum recommended daily dose. US levalbuterol label: 1.25 mg three times a day is the highest labelled dose, for more severe asthma or people who do not respond adequately to 0.63 mg, with close monitoring for systemic effects
Duolin 3 (we do not sell it)Levosalbutamol 1.25 mg with ipratropium 500 mcg in 3 mL (Cipla; PharmEasy)Same doses as this page in a larger volume

Because each Duolin respule holds 1.25 mg of levosalbutamol, in our reading of the label start dose Duolin is not suitable for someone aged 65 or over who is starting levosalbutamol: Cipla's label says that, in general, this group "should be started at a dose of 0.63 mg", with increases only as tolerated and with frequent clinical and laboratory monitoring. A move to Duolin is a decision for your doctor. If your doctor wants separate doses, we also sell Levolin 0.63mg Respules (levosalbutamol alone) and Ipravent Respules 500 (ipratropium alone), and Cipla makes a dry powder version, Duolin Rotacaps. The same number of micrograms in a different device does not mean the same dose reaches the lungs.

How to use Duolin respules

Cipla's label says Duolin is for oral inhalation only, by a standard jet nebuliser (with a face mask or mouthpiece) connected to an air compressor. These steps follow Cipla's prescribing information and the US patient instructions for the racemic version; follow the leaflet in your pack and your nebuliser maker's instructions as well.

  1. Open the foil pouch only when you are about to use a respule, and keep the unused respules in the pouch or carton (Cipla). Do not use a respule after the expiry date.
  2. Twist off the top of the respule and squeeze all the liquid into the nebuliser cup. It is for inhalation only; do not swallow it.
  3. Do not mix other medicines into the cup unless your doctor has told you to. Cipla's label says the compatibility, efficacy and safety of levosalbutamol mixed with other drugs in a nebuliser have not been established.
  4. Use a mouthpiece if you can. Cipla's label recommends a mouthpiece and says a mask, if used, must fit properly, because mist in the eyes can bring on narrow-angle glaucoma. Keep the mist away from your eyes.
  5. Sit upright, switch on the compressor and breathe calmly, deeply and evenly until no more mist comes out. The US instructions say this takes about 5 to 15 minutes.
  6. Throw away any solution left in the respule or cup (Cipla), and clean the nebuliser as its maker describes. PharmEasy's listing also advises rinsing your mouth with water afterwards.
  7. Use it at the times your doctor sets, no more than three respules a day under Cipla's label. Do not add extra doses if it seems to work less well: Cipla says to seek medical advice immediately, as this is often a sign of worsening COPD.

Starting at home. The UK label for the salbutamol version (Combivent UDVs) says (section 4.2) "Treatment should be initiated and administered under medical supervision, e.g. in the hospital setting", and that "Home based treatment can be recommended in exceptional cases (severe symptoms or experienced patients requiring higher doses) when a low dose rapid acting beta-agonist bronchodilator has been insufficient in providing relief after consultation with an experienced physician." The UK Atrovent UDVs label (ipratropium alone, section 4.4) says "Use of the nebuliser solution should be subject to close medical supervision during initial dosing." Duolin's Indian label has no such line, but in our view a first nebulised dose of any new bronchodilator combination is best taken where a doctor can see how you respond.

Storage. Cipla: store below 25°C, do not freeze, protect from light. PharmEasy also says below 25°C, and Apollo says room temperature, ideally 20 to 25°C, and marks it as not a cold chain product. It does not need a fridge. Our guide to respules, inhalers and Rotacaps explains when a nebuliser is worth it.

Groups who need extra care

  • People aged 65 and over: see above. Cipla's and the US label's usual starting dose of levosalbutamol in this group is 0.63 mg.
  • Children and teenagers: Cipla's label says there is no experience in children under 12. The US label for the racemic version says safety and effectiveness below 18 have not been established. Duolin is not a children's medicine.
  • Kidney problems: albuterol is "substantially excreted by the kidneys, and the risk of toxic reactions may be greater in patients with impaired renal function" (Cipla). The label advises care in choosing the dose and caution with high doses of levosalbutamol in kidney impairment.
  • Liver problems: Cipla says the combination has not been studied in liver impairment and should be used with caution.
  • Heart disease, high blood pressure or an irregular heartbeat; seizures; an overactive thyroid; diabetes: use with caution (Cipla). The UK label for the salbutamol version adds that people with severe heart disease should seek medical advice if they get chest pain or other signs of worsening heart disease.
  • Narrow-angle glaucoma, an enlarged prostate or trouble passing urine (bladder-outflow obstruction), cystic fibrosis: caution with the ipratropium part (Cipla).
  • Pregnancy and labour: Cipla says levosalbutamol should be used in pregnancy only if the potential benefit justifies the potential risk to the foetus, and restricts use during labour to people in whom the benefits clearly outweigh the risk.
  • Breastfeeding: Cipla's patient information says you and your doctor should decide whether you take Duolin or breastfeed, but not both.

Medicines that interact (Cipla label unless stated):

  • Other short-acting beta agonist relievers, such as salbutamol or levosalbutamol inhalers, or adrenaline (epinephrine): Cipla says avoid using them together, and use other adrenergic medicines with caution. The US label for the racemic version adds that extra albuterol or ipratropium on top of the recommended doses has not been studied. Ask your doctor what you should use for sudden breathlessness between doses.
  • Other anticholinergic medicines, including tiotropium inhalers (such as Duova) and some Parkinson's medicines: tell your doctor. The UK label for the salbutamol version says long-term use with other anticholinergic drugs "is not recommended".
  • Beta blockers: they block the effect and may cause severe bronchospasm in asthma; Cipla says people with asthma should not normally be treated with them, and where there is no acceptable alternative, a cardioselective beta blocker should be considered and given with caution.
  • Loop and thiazide diuretics (water tablets): low potassium and ECG changes can get worse; consider monitoring potassium. The UK label for the salbutamol version adds xanthines such as theophylline and steroids, and advises potassium checks in severe airway obstruction.
  • Digoxin: racemic albuterol lowered digoxin levels by 16% and 22% in volunteers; Cipla advises checking digoxin levels.
  • MAO inhibitors and tricyclic antidepressants, or within 2 weeks of stopping them: extreme caution; Cipla says consider alternative therapy.
  • Anaesthetics such as halothane: the UK label for the salbutamol version says they may increase sensitivity to the heart effects of beta agonists. Tell your anaesthetist.

Side effects

We found no published side effect table for Duolin itself. The closest data come from the US label for the racemic version, in a 12 week COPD trial with no placebo arm:

ReactionIpratropium with albuterol (765 people)Albuterol alone (761)Ipratropium alone (754)
Any adverse event48.0%43.0%43.6%
Lung disease6.4%4.7%4.5%
Sore throat (pharyngitis)4.4%3.5%3.6%
Chest pain2.6%1.4%1.9%
Diarrhoea1.8%0.7%1.2%
Urinary tract infection1.6%0.4%1.2%
Nausea1.4%0.9%0.8%
Leg cramps1.4%1.1%0.8%

Selected rows from the US label table of events in 1% or more of any group where the combination had the highest rate. Constipation and voice changes were also reported in more than 1% of people on the combination, and possible allergic reactions (rash, itching, hives) in 0.3%.

For the levosalbutamol dose in Duolin, the US levalbuterol label's 4 week asthma trial is the best guide. With 1.25 mg against placebo: nervousness 9.6% against 0%, tremor 6.8% against 0%, viral infection 12.3% against 9.3%, fast heartbeat 2.7% against 0% and dizziness 2.7% against 1.3%; heart rate 15 minutes after the first dose rose by an average of 6.9 beats a minute. The label adds that a slightly greater number of serious adverse events, discontinuations due to adverse events and clinically significant ECG changes were reported with 1.25 mg than with the other active treatments. These are separate trials of different products; do not add the tables together.

For ipratropium, Cipla's label lists headache, cough, local irritation, dry mouth, nausea and constipation, diarrhoea or vomiting as common. Beta agonists can also lower potassium (Cipla: the decrease is "usually transient, not requiring supplementation") and change blood sugar levels.

When to get urgent help

  • Breathing that gets worse quickly, or does not improve after a dose: call emergency services now (911 in the US and Canada, 999 in the UK, 000 in Australia) or go to the nearest emergency department. Cipla's patient information says: "If DUOLIN respules do not help your airways narrowing (bronchospasm) or your bronchospasm gets worse, call your doctor right away or get emergency help if needed."
  • Wheezing or breathlessness that gets worse while or straight after using it (paradoxical bronchospasm): Cipla says "Stop DUOLIN respules and call your doctor right away or get emergency help". The label says this can be life threatening and often happens with the first use of a new vial.
  • Hives or rash, swelling of the face, eyelids, lips, tongue or throat, trouble swallowing, worse wheezing or chest tightness, or collapse: Cipla lists these as symptoms of a serious allergic reaction. Stop Duolin and get emergency help (our advice).
  • Eye pain or discomfort, blurred vision, halos or coloured images around lights, with red eyes: possible acute narrow-angle glaucoma. Cipla's label says treatment with miotic (pupil-narrowing) eye drops should be started and specialist advice sought immediately; in our view this needs emergency eye care the same day.
  • Chest pain, a very fast or irregular heartbeat, fainting or a seizure.
  • Being unable to pass urine: urinary retention is a listed reaction to ipratropium, and in our view it needs urgent care.
  • Using far more than prescribed. Cipla's label says "Do not exceed the recommended dose. Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma." Overdose can cause heart rates up to 200 beats a minute, seizures and low potassium. For poisoning advice, call 1-800-222-1222 in the US or 13 11 26 in Australia.

Tell the emergency staff which nebuliser solutions and inhalers you use, how many respules you took and when.

Who should not use Duolin Respules

Never use it (contraindication, Cipla label):

  • if you have had an allergic reaction to levosalbutamol, ipratropium, any other component, or to atropine and its derivatives. The US levalbuterol label also lists allergy to racemic albuterol (salbutamol).

Contraindicated in the UK label for the salbutamol version (Combivent UDVs 4.3; Duolin's own label does not list these, but the levosalbutamol in it is a beta agonist too):

  • hypertrophic obstructive cardiomyopathy;
  • a fast heart rhythm disorder (tachyarrhythmia).

Not for:

  • children under 12 (no experience, Cipla label);
  • asthma on its own terms: Duolin's Indian label is for COPD, and Cipla's levosalbutamol section says a beta agonist alone may not be adequate to control asthma in many patients and is not a substitute for corticosteroids. If you have asthma, use it only within a plan your doctor has written.

Talk to a doctor first: heart disease, high blood pressure, an irregular heartbeat, seizures, an overactive thyroid, diabetes, low potassium, narrow-angle glaucoma, an enlarged prostate or bladder problems, cystic fibrosis, kidney or liver disease, age 65 or over, pregnancy or breastfeeding, and any of the medicines listed above.

Prescription and legal status

Indian pharmacy listings mark Duolin as a prescription medicine (Tata 1mg, Apollo), and Apollo lists it as Schedule H. The medicines closest to it are prescription only in all four countries we ship to: ipratropium with albuterol solution in the US ("Rx only"), Combivent UDVs and Atrovent UDVs in the UK (POM), Teva-Combo Sterinebs and other ipratropium solutions in Canada, and ipratropium nebuliser solutions in Australia (Schedule 4). Duolin itself is not approved by the FDA or Health Canada, and we found no MHRA licence or TGA registration. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. COPD needs regular review by a doctor or nurse, including a plan for flare-ups. Check the rules where you live.

Buying genuine Duolin

The MHRA warns: "Any medicine not authorised for sale in the UK can be unsafe or ineffective and there is no way of knowing what is in them or the negative health effects they can have." It also advises: "Only use UK-registered pharmacies, including online pharmacies displaying the official green cross logo." That warning covers Duolin, which is not authorised in the UK.

Check the composition on the carton. The Duolin name is not the same product everywhere: in South Africa, Cipla's Duolin Respules contain salbutamol 2.5 mg with ipratropium 0.5 mg (SAHPRA leaflet, revised 6 February 2026), not levosalbutamol. The Indian pack this page describes should read levosalbutamol 1.25 mg and ipratropium 500 mcg, name Cipla, and show a batch number and an expiry date, and the solution should be clear. These checks cannot prove a product is genuine, because counterfeiters copy packaging. If the respules do not seem to work the way your previous supply did, see a doctor rather than taking extra doses. If a batch causes unusual symptoms, seek medical advice and report it to your medicines regulator (the MHRA Yellow Card scheme in the UK, FDA MedWatch in the US, the TGA in Australia or Health Canada) as well as to us.

Delivery

We ship Duolin Respules to the US, UK, Australia and Canada in plain packaging with tracking. Standard delivery takes 7 to 14 business days to most countries, so order well before your current supply runs out and do not rely on an order from us for a flare-up. Shipping costs a flat $25 on orders under $149 and is free from $149. See our shipping page and refund policy.

Related guides

Sources

  • Cipla Limited. DUOLIN Respules (levosalbutamol sulphate and ipratropium bromide) prescribing information and patient counselling information, CiplaMed product index, accessed 22 October 2026: composition, indication, posology, contraindications, warnings, interactions, special populations, undesirable effects, overdose, pharmacology, storage, manufacturer and licence. CiplaMed
  • Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (Cipla USA), US prescribing information and patient information, DailyMed setid 3c64255e-074c-41f8-a344-3686a0685020, version 7, June 2026: Clinical Pharmacology, Indications, Contraindications, Warnings, Precautions, Adverse Reactions, Dosage and Administration. DailyMed
  • Ipratropium Bromide Inhalation Solution 0.02% (Ritedose), US prescribing information, DailyMed setid 22479633-624a-4251-ad3c-1dcba5d503fb, version 17, December 2025. DailyMed
  • Levalbuterol Inhalation Solution, USP (Ritedose), US prescribing information and patient leaflet, DailyMed setid d6998949-e1cb-4c86-a480-c0dfd9cb75b5, December 2025, sections 2, 4, 6.1, 12.2, 12.3 and 14. DailyMed
  • Combivent UDVs (ipratropium bromide and salbutamol). UK summary of product characteristics, PL 00015/0197, revised 14 September 2026, sections 2 and 4.1 to 4.9. emc
  • Atrovent UDVs, 2 ml (ipratropium bromide). UK summary of product characteristics, revised 22 March 2021, sections 4.1 to 4.6. emc
  • US FDA drug approvals (openFDA drugsfda): DuoNeb (NDA 020950) and Atrovent solution (NDA 020228) discontinued with Federal Register determinations; no levalbuterol with ipratropium product; searched 22 October 2026. openFDA
  • Health Canada Drug Product Database, ipratropium and levalbuterol searches, 22 October 2026. Health Canada DPD
  • healthdirect Australia, ipratropium and ipratropium with salbutamol medicine pages, accessed 22 October 2026; GenRx Ipratropium Nebuliser Solution consumer medicine information (S4). healthdirect
  • Central Drugs Standard Control Organisation. Fixed dose combinations approved by DCG(I) since 1961 to 31 December 2019, item 301 (ipratropium 500 mcg with salbutamol 2.5 mg per 2.5 ml respiratory solution, 03.04.2001), and later lists to 2025. CDSCO
  • SAHPRA. DUOLIN Respules 0.5 mg/2.5 mg in 2.5 mL patient information leaflet, Cipla Medpro, revised 6 February 2026. SAHPRA
  • Bonasia PJ, et al. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium. Respir Care 2008. PMID 19025708.
  • Donohue JF, et al. Evaluation of the efficacy and safety of levalbuterol in subjects with COPD. COPD 2006;3(3):125-32. PMID 17240614.
  • Cydulka RK, Emerman CL, Muni A. Levalbuterol versus levalbuterol plus ipratropium in the treatment of severe acute asthma. J Asthma 2010;47(10):1094-100. PMID 20923385.
  • Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 file dated 21 October 2026: ipratropium-albuterol 0.5-3(2.5) mg/3 mL, levalbuterol 1.25 mg/3 mL and ipratropium 0.02% rows. data.medicaid.gov
  • PharmEasy, Apollo Pharmacy and Tata 1mg. Duolin, Duolin 3 and Duolin LD respules (Cipla) listings, accessed 22 October 2026. PharmEasy, Apollo
  • MHRA. 20 million illegal erectile dysfunction pills seized as MHRA warns against risky online buys, 13 February 2026. GOV.UK
  • US Food and Drug Administration. Personal Importation. FDA

This page is for information and is not medical advice. Levosalbutamol and ipratropium are prescription medicines; your doctor should set your dose and your COPD action plan.

Frequently asked questions

What is Duolin Respules?

Duolin Respules is Cipla's nebuliser solution for COPD. Each 2.5 mL respule contains levosalbutamol sulphate 1.25 mg, a short-acting beta2 agonist bronchodilator, and ipratropium bromide 500 mcg, a short-acting anticholinergic bronchodilator (Cipla prescribing information; PharmEasy and Apollo listings). Cipla's label is for people with COPD already on a regular bronchodilator who still have bronchospasm and need a second bronchodilator. No levosalbutamol with ipratropium product is approved by the FDA or Health Canada, and we found no MHRA licence or TGA registration.

Is Duolin the same as DuoNeb or Combivent UDVs?

No. DuoNeb (now sold in the US only as generic ipratropium and albuterol solution) and the UK's Combivent UDVs contain ipratropium 0.5 mg with racemic salbutamol (albuterol) 2.5 mg. Duolin contains levosalbutamol 1.25 mg, the active R form on its own, which is the same amount of the R form as in 2.5 mg salbutamol (our arithmetic). The US levalbuterol label found 1.25 mg gave about twice the R-albuterol exposure of 2.5 mg racemic albuterol and a slightly higher rate of systemic beta agonist side effects. We found no published clinical trial of Duolin itself. In South Africa, Cipla's Duolin Respules contain salbutamol, not levosalbutamol, so check your carton.

What does Duolin Respules cost per respule?

As of October 2026, $33.00 for 30 respules ($1.10 each), $52.50 for 60 ($0.88 each) and $73.75 for 90 ($0.82 each), before shipping. All packs are under $149, so each order carries $25 shipping: $1.93, $1.29 or $1.10 a respule with shipping. The pack selector shows the current price. In the US, the licensed ipratropium and albuterol solution costs pharmacies about $0.23 to $0.24 a vial (NADAC, 21 October 2026), far less than ours.

How do I use Duolin respules, and how often?

Cipla's label gives one respule three times a day, every 6 to 8 hours, for adults and children over 12, and calls this the maximum recommended daily dose. Open the foil pouch just before use, twist off the top, squeeze all the liquid into a jet nebuliser cup, and breathe the mist through a mouthpiece (or a well-fitting mask) until no more mist comes out. Keep the mist out of your eyes, do not mix other medicines into the cup unless your doctor says so, and throw away any solution left over.

Which Duolin should I choose: Duolin, Duolin 3 or Duolin LD?

We sell only Duolin Respules 2.5 mL (levosalbutamol 1.25 mg with ipratropium 500 mcg). Duolin 3 has the same doses in 3 mL. Duolin LD has levosalbutamol 0.63 mg with ipratropium 500 mcg (PharmEasy). Cipla's label and the US levalbuterol label say that, in general, people aged 65 and over should be started on 0.63 mg of levosalbutamol. In our reading of that start dose, Duolin is not suitable for someone in that group who is starting levosalbutamol. Which product you use is your doctor's decision.

How fast does Duolin work and how long does it last?

Cipla's patient information says Duolin may help open your airways for up to 5 hours. We have no Duolin-specific timing data. In the US label's 12 week COPD trial of the racemic version (ipratropium with albuterol, 863 people), the mean time to peak lung function was 1.5 hours and a 15% improvement lasted 4.3 hours. If it stops giving its usual relief, Cipla says to seek medical advice immediately, as this is often a sign of worsening COPD.

Can Duolin be used for asthma or for children?

Cipla's label is for COPD, and it says there is no experience in children under 12. Its levosalbutamol section says a beta agonist alone may not be adequate to control asthma in many patients and is not a substitute for corticosteroids. If you have asthma, use Duolin only within a plan your doctor has written, alongside the preventer they prescribe (our advice).

What are the side effects of Duolin?

There is no published side effect table for Duolin itself. In the US 12 week COPD trial of ipratropium with albuterol, lung disease (6.4%), sore throat (4.4%) and chest pain (2.6%) were among the events more common than with either medicine alone. With levalbuterol 1.25 mg in a 4 week asthma trial, nervousness (9.6%) and tremor (6.8%) were more common than with placebo (0%). Ipratropium commonly causes dry mouth, headache, cough and nausea (Cipla). Worsening breathing straight after a dose, allergy signs or eye pain with blurred vision need urgent help.

Who should not use Duolin Respules?

Never use it if you are allergic to levosalbutamol, salbutamol, ipratropium, atropine or its derivatives, or any other component (Cipla and US labels). The UK label for the salbutamol version also lists hypertrophic obstructive cardiomyopathy and tachyarrhythmia as contraindications. Talk to a doctor first if you have heart disease, high blood pressure, seizures, an overactive thyroid, diabetes, narrow-angle glaucoma, an enlarged prostate or bladder problems, kidney or liver disease, are 65 or over, pregnant or breastfeeding, or take beta blockers, water tablets, digoxin, MAO inhibitors, tricyclic antidepressants, other relievers or other anticholinergic medicines such as tiotropium.

Do I need a prescription for Duolin?

Indian listings mark Duolin as a prescription medicine (Apollo lists it as Schedule H). The closest licensed products, ipratropium with salbutamol solutions and ipratropium solutions, are prescription only in the US, UK, Canada and Australia. Duolin itself is not approved by the FDA or Health Canada, and we found no MHRA licence or TGA registration. In the US, the FDA says personal importation of unapproved medicines is illegal in most circumstances. COPD needs regular review by a doctor or nurse.

How long does delivery take?

We ship Duolin Respules to the US, UK, Australia and Canada in plain, tracked packaging. Standard delivery takes 7 to 14 business days, so order well before your current supply runs out and never rely on an order from us during a flare-up. Shipping is a flat $25 on orders under $149 and free from $149. Cipla's label says store below 25 C, do not freeze and protect from light; it does not need a fridge.

Medical References

  1. 1.ClinicalTrials.gov NCT00400153

Sources: U.S. National Library of Medicine (DailyMed, PubMed), openFDA

Guide to AsthmaHow asthma medicines actually work: relievers, inhaled steroids, combination inhalers and leukotriene tablets, with the 2019 guideline change that ended reliever-only treatment.

Related articles

Customer Reviews

No reviews yet. Bought Duolin Respules? Tell other buyers how it went.